These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25818503)

  • 21. Endocannabinoids in Alzheimer's disease and their impact on normative cognitive performance: a case-control and cohort study.
    Koppel J; Bradshaw H; Goldberg TE; Khalili H; Marambaud P; Walker MJ; Pazos M; Gordon ML; Christen E; Davies P
    Lipids Health Dis; 2009 Jan; 8():2. PubMed ID: 19144193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F; Brugnolo A; Calvini P; Copello F; De Leo C; Girtler N; Morbelli S; Piccardo A; Vitali P; Rodriguez G
    Clin Neurophysiol; 2005 Feb; 116(2):364-75. PubMed ID: 15661114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical presentation of Moroccan cases with Alzheimer's disease].
    El Kadmiri N; Zaid Y; Hamzi K; Nadifi S; Slassi I; El Moutawakil B
    Encephale; 2014 Dec; 40(6):481-6. PubMed ID: 25127896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower circulating endocannabinoid levels in children with autism spectrum disorder.
    Aran A; Eylon M; Harel M; Polianski L; Nemirovski A; Tepper S; Schnapp A; Cassuto H; Wattad N; Tam J
    Mol Autism; 2019; 10():2. PubMed ID: 30728928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
    Sarchielli P; Pini LA; Coppola F; Rossi C; Baldi A; Mancini ML; Calabresi P
    Neuropsychopharmacology; 2007 Jun; 32(6):1384-90. PubMed ID: 17119542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity.
    Gatta-Cherifi B; Matias I; Vallée M; Tabarin A; Marsicano G; Piazza PV; Cota D
    Int J Obes (Lond); 2012 Jun; 36(6):880-5. PubMed ID: 21844878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia.
    Altamura C; Scrascia F; Quattrocchi CC; Errante Y; Gangemi E; Curcio G; Ursini F; Silvestrini M; Maggio P; Beomonte Zobel B; Rossini PM; Pasqualetti P; Falsetti L; Vernieri F
    J Clin Neurol; 2016 Apr; 12(2):201-8. PubMed ID: 27074295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.
    Patsenker E; Sachse P; Chicca A; Gachet MS; Schneider V; Mattsson J; Lanz C; Worni M; de Gottardi A; Semmo M; Hampe J; Schafmayer C; Brenneisen R; Gertsch J; Stickel F; Semmo N
    Int J Mol Sci; 2015 Mar; 16(4):7057-76. PubMed ID: 25826533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of 2-Arachidonoylglycerol by μSPE-LC-MS/MS.
    Battista N; Sergi M
    Methods Mol Biol; 2016; 1412():19-26. PubMed ID: 27245888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of endocannabinoids in postmortem brain of schizophrenic subjects.
    Muguruza C; Lehtonen M; Aaltonen N; Morentin B; Meana JJ; Callado LF
    Schizophr Res; 2013 Aug; 148(1-3):145-50. PubMed ID: 23800614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer's dementia.
    Huang CW; Tsai MH; Chen NC; Chen WH; Lu YT; Lui CC; Chang YT; Chang WN; Chang AY; Chang CC
    Thromb Haemost; 2015 Nov; 114(6):1230-40. PubMed ID: 26289958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocannabinoid signalling in Alzheimer's disease.
    Maroof N; Pardon MC; Kendall DA
    Biochem Soc Trans; 2013 Dec; 41(6):1583-7. PubMed ID: 24256258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats.
    Manduca A; Morena M; Campolongo P; Servadio M; Palmery M; Trabace L; Hill MN; Vanderschuren LJ; Cuomo V; Trezza V
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1362-74. PubMed ID: 25914159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of cerebral hemodynamic parameters by QUASAR arterial spin labeling in Alzheimer's disease and cognitively normal Elderly adults at 3-tesla.
    Mak HK; Chan Q; Zhang Z; Petersen ET; Qiu D; Zhang L; Yau KK; Chu LW; Golay X
    J Alzheimers Dis; 2012; 31(1):33-44. PubMed ID: 22504315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoid Response in Acute Ischemic Stroke: Elevated 2-Arachidonoylglycerol.
    Buciuc M; Conte GM; Scharf EL
    Stroke; 2021 May; 52(5):e131-e132. PubMed ID: 33827241
    [No Abstract]   [Full Text] [Related]  

  • 37. Endocannabinoid system and cardiometabolic risk factors: A comprehensive systematic review insight into the mechanistic effects of omega-3 fatty acids.
    Saleh-Ghadimi S; Kheirouri S; Maleki V; Jafari-Vayghan H; Alizadeh M
    Life Sci; 2020 Jun; 250():117556. PubMed ID: 32184122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constructional apraxia as a distinctive cognitive and structural brain feature of pre-senile Alzheimer's disease.
    Serra L; Fadda L; Perri R; Spanò B; Marra C; Castelli D; Torso M; Makovac E; Cercignani M; Caltagirone C; Bozzali M
    J Alzheimers Dis; 2014; 38(2):391-402. PubMed ID: 23969996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.
    Centonze D; Bari M; Rossi S; Prosperetti C; Furlan R; Fezza F; De Chiara V; Battistini L; Bernardi G; Bernardini S; Martino G; Maccarrone M
    Brain; 2007 Oct; 130(Pt 10):2543-53. PubMed ID: 17626034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.
    Nicholson J; Azim S; Rebecchi MJ; Galbavy W; Feng T; Reinsel R; Rizwan S; Fowler CJ; Benveniste H; Kaczocha M
    PLoS One; 2015; 10(4):e0123132. PubMed ID: 25835291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.